Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-056808)

Filing Details

Accession Number:: 0001209191-18-056808
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-01 17:25:44
Reporting Period:: 2018-10-30

Accepted Time:: 2018-11-01 17:25:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1659323	Iterum Therapeutics Plc	ITRM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1734389	Mark Chin	C/O Iterum Therapeutics Plc, Blk 2 Fl. 3, Harcourt Centre, Harcourt St. Dublin L2 2		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2018-10-30	58,000	$6.10	1,089,903	No	4	P	Indirect	By Arix Bioscience Holdings Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Arix Bioscience Holdings Ltd.

Footnotes

The Reporting Person is an Investment Director for Arix Bioscience Holdings Ltd.